a-Gal and other recent findings that have informed our understanding of anaphylaxis
Annals of Allergy, Asthma & Immunology
February 2020 Volume 124, Issue 2, Pages 135-142 CME Review
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Physicians involved in providing patient care in the field of allergy/asthma/immunology
Learning Objectives
At the conclusion of this activity, participants should be able to:
• Recognize that anaphylaxis represents an over-exuberant manifestation of a form of immunity
which evolved to combat toxins and other threats to the skin and mucosa.
• Describer the effects of early oral introduction of allergenic foods and emerging work on the
microbiome on management of food allergy.
* Compare the features if the a-Gal syndrome to other forms of anaphylaxis
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance